NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
1-Year Return
85.82%
This Quarter Return
+38.25%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$3.79B
AUM Growth
+$1.43B
(+60%)
Cap. Flow
+$832M
Cap. Flow
% of AUM
21.96%
Top 10 Holdings %
Top 10 Hldgs %
59.79%
Holding
60
New
6
Increased
1
Reduced
4
Closed
3
Top Buys
| 1 |
DM
Desktop Metal, Inc.
DM
|
$489M |
| 2 |
EAR
Eargo, Inc. Common Stock
EAR
|
$292M |
| 3 |
Opendoor
OPEN
|
$152M |
| 4 |
Palo Alto Networks
PANW
|
$95.5M |
| 5 |
Upstart Holdings
UPST
|
$23.4M |
Top Sells
| 1 |
Sprout Social
SPT
|
$114M |
| 2 |
Mersana Therapeutics
MRSN
|
$111M |
| 3 |
ALLK
Allakos
ALLK
|
$14.5M |
| 4 |
Senseonics Holdings
SENS
|
$2.34M |
| 5 |
DraftKings
DKNG
|
$1.41M |
Sector Composition
| 1 | Healthcare | 65.71% |
| 2 | Industrials | 13.91% |
| 3 | Technology | 12.51% |
| 4 | Real Estate | 4% |
| 5 | Consumer Discretionary | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Marker Therapeutics
MRKR
$11.4M
| $7.25M | 0.19% |
500,000
| – | – |
|
|
PHXM
52
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $5.77M | 0.15% |
62,500
| – | – |
|
|
TCON
53
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $4.06M | 0.11% |
17,336
| – | – |
|
54
Tempest Therapeutics
TPST
$45.6M
| $3.78M | 0.1% |
9,060
| – | – |
|
55
Palantir
PLTR
$370B
| $1.41M | 0.04% |
59,980
-14,994
| -20% | -$353K |
|
|
AKTX
56
Akari Therapeutics
AKTX
$24.1M
| $837K | 0.02% |
22,608
| – | – |
|
|
VIRX
57
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $258K | 0.01% |
37,093
| – | – |
|
|
58
DraftKings
DKNG
$22.9B
| – | – |
-23,902
| Closed | -$1.41M |
|
|
59
Mersana Therapeutics
MRSN
$34.5M
| – | – |
-238,381
| Closed | -$111M |
|
|
ALTR
60
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| – | – |
-11,977
| Closed | -$503K |
|